You have read all your free articles, to continue reading subscribe to read the rest of this content.
Following a one-year succession process, Miguel Calado will succeed Rabbe Klemets, who is moving into an advisory position. Non-executive board member, Mads Laustsen, will assume Calado's previous role of Vice Chairman. An experienced board member Since joining Nanoform’s board last year as VAlready a subscriber Login You have read all…
Teva Pharmaceutical Industries has announced that its Board of Directors has named Kåre Schultz to become the company’s President and Chief Executive Officer. Schultz will succeed Dr. Yitzhak Peterburg, who will continue to serve as Interim Chief Executive Officer until Mr. Schultz joins the Already a subscriber Login You have read…
The European Spallation Source ERIC Council has named John Womersley, CEO of the UK’s Science and Technology Facilities Council (STFC), the next Director General. He joins the ESS project on November 1, taking over from current DG, Jim Yeck. "John has great experience as a scientist, a leader oAlready a…
Innovation, social responsibility, and loyal employees—these are most important traits of a workplace, according to an international survey of biotech and pharma employees. The survey is conducted annually by Science, the journal of the American Association for the Advancement of ScienAlready a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest…
